Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis

NCT05488327 is registered in ClinicalTrials.gov with Jiangxi Provincial People's Hopital as lead sponsor.

NCT NCT05488327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05488327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis
Lead sponsor
Jiangxi Provincial People's Hopital
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2022
Completion date
September 1, 2023
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis